Perioperative/periprocedural effects of statin treatment for patients undergoing vascular surgery or endovascular procedures: An update

Current Vascular Pharmacology

Volumn 11, Issue 1, 2013, Pages 112-120

  Paraskevas, Kosmas I ^a   Veith, Frank J ^b   Liapis, Christos D ^c   Mikhailidis, Dimitri P ^d  

^a RED CROSS HOSPITAL   (Greece)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Endovascular procedures; Perioperative effects; Pleiotropic effects; Postoperative complications; Statins; Vascular surgery

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; ENDOVASCULAR SURGERY; HEART INFARCTION; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LOADING DRUG DOSE; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; VASCULAR SURGERY;

EID: 84873148475     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/157016113804547656     Document Type: Review

References (75)

1. Schouten O, Boersma E, Hoeks SE, et al. Dutch Echocardiograpic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 2009; 361: 980-9.
2. Paraskevas KI, Hamilton G, Mikhailidis DP. Statins: an essential component in the management of carotid artery disease. J Vasc Surg 2007; 46: 373-86.
3. Paraskevas KI, Liapis CD, Hamilton G, Mikhailidis DP. Are statins an option in the management of abdominal aortic aneurysms? Vasc Endovascular Surg 2008; 42: 128-34.
4. Paraskevas KI, Athyros VG, Briana DD, Kakafika AI, Karagiannis A, Mikhailidis DP. Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures. Curr Drug Targets 2007; 8: 942-51.
5. Paraskevas KI, Liapis CD, Hamilton G, Mikhailidis DP. Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery? Eur J Vasc Endovasc Surg 2006; 32: 286-93.
6. Jasinska M, Owczarek J, Orszulak-Michalak D. Statins: a new insight into their mechanisms of action and consequent pleiotropic effects. Pharmacol Rep 2007; 59: 483-99.
7. Merla R, Daher IN, Ye Y, Uretsky BF, Birnbaum Y. Pretreatment with statins may reduce cardiovascular morbidity and mortality after elective surgery and percutaneous coronary intervention: clinical evidence and possible underlying mechanisms. Am Heart J 2007; 154: 391-402.
8. Feldman LS, Brotman DJ. Perioperative statins: more than lipidlowering? Cleve Clin J Med 2008; 75: 654-62.
9. Tsiara S, Elisaf M, Mikhailidis DP. Early vascular benefits of statin therapy. Curr Med Res Opin 2003; 19: 540-56.
10. Feringa HH, Schouten O, Karagiannis SE, et al. Intensity of statin therapy in relation to myocardial ischemia, troponin T release, and clinical cardiac outcome in patients undergoing major vascular surgery. J Am Coll Cardiol 2007; 50: 1649-56.
11. Veselka J, Procházková S, Duchonová R, Homolová I, Tesar D, Bybee KA. Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention. Heart Vessels 2006; 21: 146-51.
12. Hara H, Nakamura M, Yokouchi I, et al. Aggressive statin therapy in multicenter and effectiveness for the reduction of intramyocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study. Ther Adv Cardiovasc Dis 2009; 3: 357-65.
13. Desai H, Aronow WS, Ahn C, et al. Incidence of perioperative myocardial infarction and of 2-year mortality in 577 elderly patients undergoing noncardiac vascular surgery treated with and without statins. Arch Gerontol Geriatr 2010; 51: 149-51.
14. Winkel TA, Schouten O, Voûte MT, et al. The effect of statins on perioperative events in patients undergoing vascular surgery. Acta Chir Belg 2010; 110: 28-31.
15. Kennedy J, Quan H, Buchan AM, Ghali WA, Feasby TE. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke 2005; 36: 2072-6.
16. Brooke BS, McGirt MJ, Woodworth GF, et al. Preoperative statin and diuretic use influence the presentation of patients undergoing carotid endarterectomy: results of a large single-institution casecontrol study. J Vasc Surg 2007; 45: 298-303.
17. McGirt MJ, Perler BA, Brooke BS, et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg 2005; 42: 829-36.
18. Welten GM, Chonchol M, Schouten O, et al. Statin use is associated with early recovery of kidney injury after vascular surgery and improved long-term outcome. Nephrol Dial Transplant 2008; 23: 3867-73.
19. Moulakakis KG, Matoussevitch V, Borgonio A, Gawenda M, Brunkwall J. Evidence that statins protect renal function during endovascular repair of AAAs. Eur J Vasc Endovasc Surg 2010; 40: 608-15.
20. Le Manach Y, Ibanez Esteves C, Bertrand M, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing vascular surgery. Anesthesiology 2011; 114: 98-104.
21. Welten GM, Chonchol M, Hoeks SE, et al. Statin therapy is associated with improved outcomes in vascular surgery patients with renal impairment. Am Heart J 2007; 154: 954-61.
22. Youssef F, Gupta P, Seifalian AM, Myint F, Mikhailidis DP, Hamilton G. The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease. Angiology 2004; 55: 53-62.
23. Athyros VG, Mikhailidis DP, Papageorgiou AA, et al. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study. J Clin Pathol 2004; 57: 728-34.
24. Azizzadeh A, Sanchez LA, Miller CC 3rd, et al. Glomerular filtration rate is a predictor of mortality after endovascular abdominal aortic aneurysm repair. J Vasc Surg 2006; 43: 14-8.
25. Soong CV, Makar RR, O'Donnell ME, Badger SA, Lee B, Sharif MA. Effect of preoperative renal dysfunction on mortality and postoperative renal failure following endovascular abdominal aortic aneurysm repair. Vasc Endovascular Surg 2008; 42: 427-32.
26. Maithel SK, Pomposelli FB, Williams M, et al. Creatinine clearance but not serum creatinine alone predicts long-term postoperative survival after lower extremity revascularization. Am J Nephrol 2006; 26: 612-20.
27. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 (Suppl 1): S1-75.
28. Weng TC, Yang YH, Lin SJ, Tai SH. A systematic review and meta-analysis on the therapeutic equivalence of statins. J Clin Pharm Ther 2010; 35: 139-51.
29. Grines CL. The role of statins in reversing atherosclerosis: what the latest regression studies show. J Interv Cardiol 2006; 19: 3-9.
30. Smith ME, Lee NJ, Haney E, Carson S. Drug class reviews: HMGCoA reductase inhibitors (statins) and fixed-dose combination products containing a statin. Final report. Update 5. Portland: Oregon Health & Science University. November 2009. Available at: http://www.ncbi.nlm.nih.gov/books/NBK47273/pdf/TOC.pdf
31. Yun KH, Jeong MH, Oh SK, et al. The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome. Int J Cardiol 2009; 137: 246-51.
32. Cay S, Cagirci G, Sen N, Balbay Y, Durmaz T, Aydogdu S. Prevention of peri-procedural myocardial injury using a single high loading dose of rosuvastatin. Cardiovasc Drugs Ther 2010; 24: 41-7.
33. Briguori C, Visconti G, Focaccio A, et al. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. J Am Coll Cardiol 2009; 54: 2157-63.
34. Baigent C, Keech A, Kearney PM, et al. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterollowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-78.
35. Heart Protection Study Collaborative Group, Bulbulia R, Bowman L, Wallendszus K, et al. Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial. Lancet 2011; 378: 2013-20.
36. Fleischmann KE, Goldman L, Young B, Lee TH. Association between cardiac and noncardiac complications in patients undergoing noncardiac surgery: outcomes and effects on length of stay. Am J Med 2003; 115: 515-20.
37. Devereaux PJ, Goldman L, Yusuf S, Gilbert K, Leslie K, Guyatt GH. Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review. CMAJ 2005; 173: 779-88.
38. Sheifer SE, Manolio TA, Gersh BJ. Unrecognized myocardial infarction. Ann Intern Med 2001; 135: 801-11.
39. Perler BA. Should statins be given routinely before carotid endarterectomy? Perspect Vasc Surg Endovasc Ther 2007; 19: 240-5.
40. Gröschel K, Ernemann U, Schulz JB, Nägele T, Terborg C, Kastrup A. Statin therapy at carotid angioplasty and stent placement: effect on procedure-related stroke, myocardial infarction, and death. Radiology 2006; 240: 145-51.
41. Verzini F, De Rango P, Parlani G, et al. Effects of statins on early and late results of carotid stenting. J Vasc Surg 2011; 53: 71-9.
42. Koutouzis M, Nomikos A, Nikolidakis S, et al. Statin treated patients have reduced intraplaque angiogenesis in carotid endarterectomy specimens. Atherosclerosis 2007; 192: 457-63.
43. Kadoglou NP, Sailer N, Moumtzouoglou A, Kapelouzou A, Gerasimidis T, Liapis CD. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization. J Vasc Surg 2010; 51: 114-21.
44. Koutouzis M, Paraskevas KI, Rallidis LS, et al. Statin treatment, carotid atherosclerotic plaque macrophage infiltration and circulating inflammatory markers. Open Cardiovasc Med J 2008; 2: 110-4.
45. Paraskevas KI, Giannoukas AD, Kotsikoris I, Mikhailidis DP. Contrast-induced nephropathy and the vascular patient. Angiology 2010; 61: 721-3.
46. Zhao JL, Yang YJ, Zhang YH, You SJ, Wu YJ. Gao RL. Effect of statins on contrast-induced nephropathy in patients with acute myocardial infarction treated with primary angioplasty. Int J Cardiol 2008; 126: 435-6.
47. Patti G, Nusca A, Chello M, et al. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention. Am J Cardiol 2008; 101: 279-85.
48. Xinwei J, Xianghua F, Jing Z, et al. Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol 2009; 104: 519-24.
49. Feringa HH, Karagiannis S, Vidakovic R, et al. Comparison of the incidences of cardiac arrhythmias, myocardial ischemia, and cardiac events in patients treated with endovascular versus open surgical repair of abdominal aortic aneurysms. Am J Cardiol 2007; 100: 1479-84.
50. Dong L, Zhang F, Shu X. Usefulness of statins pretreatment for the prevention of postoperative atrial fibrillation in patients undergoing cardiac surgery. Ann Med 2011; 43: 69-74.
51. Winchester DE, Wen X, Xie L, Bavry AA. Evidence of preprocedural statin therapy a meta-analysis of randomized trials. J Am Coll Cardiol 2010; 56: 1099-109.
52. Banach M, Kourliouros A, Reinhart KM, et al. Postoperative atrial fibrillation-what do we really know? Curr Vasc Pharmacol 2010; 8: 553-72.
53. Rahimi K, Emberson J, McGale P, et al. PROSPER Executive. Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. BMJ 2011; 342: d1250.
54. Yin L, Wang Z, Wang Y, Ji G, Xu Z. Effect of statins in preventing postoperative atrial fibrillation following cardiac surgery. Heart Lung Circ 2010; 19: 579-83.
55. Kim JS, Kim J, Choi D, et al. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in STsegment elevation myocardial infarction: the STATIN STEMI trial. JACC Cardiovasc Interv 2010; 3: 332-9.
56. Athyros VG, Tziomalos K, Florentin M, Karagiannis A, Mikhailidis DP. Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect? Curr Med Res Opin 2010; 26: 839-42.
57. Nusca A, Melfi R, Patti G, Di Sciascio G. Statin loading for acute coronary syndromes. Curr Opin Cardiol 2010; 25: 373-8.
58. Paraskevas KI, Mikhailidis DP, Veith FJ. Optimal statin type and dosage for vascular patients. J Vasc Surg 2011; 53: 837-44.
59. Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with Atorvastatin: a randomized trial. J Vasc Surg 2004; 39: 967-75.
60. Le Manach Y, Godet G, Coriat P, et al. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg 2007; 104: 1326-33.
61. Schouten O, Hoeks SE, Welten GM, et al. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. Am J Cardiol 2007; 100: 316-20.
62. Tziomalos K, Athyros VG, Mikhailidis DP. Statin discontinuation: an underestimated risk? Curr Med Res Opin 2008; 24: 3059-62.
63. McNally MM, Agle SC, Parker FM, Bogey WM, Powell CS, Stoner MC. Preoperative statin therapy is associated with improved outcomes and resource utilization in patients undergoing aortic aneurysm repair. J Vasc Surg 2010; 51: 1390-6.
64. Kajimoto K, Miyauchi K, Kasai T, et al. Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun Nterminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall. Atherosclerosis 2009; 206: 505-11.
65. Rahman MN, Khan JA, Mazari FA, Mockford K, McCollum PT, Chetter IC. A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. Ann Vasc Surg 2011; 25: 32-8.
66. Silva MA, Swanson AC, Gandhi PJ, Tataronis GR. Statin-related adverse events: a meta-analysis. Clin Ther 2006; 28: 26-35.
67. Molokhia M, McKeigue P, Curcin V, Majeed A. Statin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006. PLoS One 2008; 3: e2522.
68. Rosenson RS. Current overview of statin-induced myopathy. Am J Med 2004; 116: 408-16.
69. Staffa JA, Chang J, Green L. Cerivastatin and reports of fatal rhabdomyolysis. N Engl J Med 2002; 346: 539-40.
70. Whayne TF Jr. Statin myopathy: significant problem with minimal awareness by clinicians and no emphasis by clinical investigators. Angiology 2011; 62: 415-21.
71. Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, Armitage J, Bowman L. Wallendszus K, et al. Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial. Lancet 2010; 376: 1658-69.
72. Egan A, Colman E. Weighing the benefits of high-dose simvastatin against the risk of myopathy. N Engl J Med 2011; 365: 285-7.
73. Athyros VG, Tziomalos K, Gossios TD, et al. GREACE Study Collaborative Group. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post hoc analysis. Lancet 2010; 376: 1916-22.
74. Bader T. Liver tests are irrelevant when prescribing statins. Lancet 2010; 376: 1882-3.
75. Al-Omran M, Mamdani MM, Lindsay TF, Melo M, Juurlink DN, Verma S; Systematic Assessment of Vascular Risk Investigators. Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study. J Vasc Surg 2008; 48: 607-12.